These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 35859223)

  • 1. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management.
    Lazow MA; Palmer JD; Fouladi M; Salloum R
    Neurotherapeutics; 2022 Oct; 19(6):1733-1751. PubMed ID: 35859223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time.
    Holgado BL; Guerreiro Stucklin A; Garzia L; Daniels C; Taylor MD
    Annu Rev Genomics Hum Genet; 2017 Aug; 18():143-166. PubMed ID: 28475368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Pediatric Medulloblastoma.
    Jackson K; Packer RJ
    Curr Neurol Neurosci Rep; 2023 Dec; 23(12):841-848. PubMed ID: 37943476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
    Gupta T; Shirsat N; Jalali R
    Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medulloblastoma genomics in the modern molecular era.
    Kumar R; Liu APY; Northcott PA
    Brain Pathol; 2020 May; 30(3):679-690. PubMed ID: 31799776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastoma: from molecular pathology to therapy.
    Rossi A; Caracciolo V; Russo G; Reiss K; Giordano A
    Clin Cancer Res; 2008 Feb; 14(4):971-6. PubMed ID: 18281528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management of medulloblastoma in adults.
    Eisenstat DD
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):795-802. PubMed ID: 15485314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pre-clinical utility of genomics in medulloblastoma.
    Nör C; Ramaswamy V
    Expert Rev Neurother; 2018 Aug; 18(8):633-647. PubMed ID: 30032687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
    Schwalbe EC; Lindsey JC; Nakjang S; Crosier S; Smith AJ; Hicks D; Rafiee G; Hill RM; Iliasova A; Stone T; Pizer B; Michalski A; Joshi A; Wharton SB; Jacques TS; Bailey S; Williamson D; Clifford SC
    Lancet Oncol; 2017 Jul; 18(7):958-971. PubMed ID: 28545823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling pathway deregulation and molecular alterations across pediatric medulloblastomas.
    Lhermitte B; Blandin AF; Coca A; Guerin E; Durand A; Entz-Werlé N
    Neurochirurgie; 2021 Feb; 67(1):39-45. PubMed ID: 29776650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
    Ramaswamy V; Remke M; Bouffet E; Bailey S; Clifford SC; Doz F; Kool M; Dufour C; Vassal G; Milde T; Witt O; von Hoff K; Pietsch T; Northcott PA; Gajjar A; Robinson GW; Padovani L; André N; Massimino M; Pizer B; Packer R; Rutkowski S; Pfister SM; Taylor MD; Pomeroy SL
    Acta Neuropathol; 2016 Jun; 131(6):821-31. PubMed ID: 27040285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches.
    Menyhárt O; Győrffy B
    Cancer Metastasis Rev; 2020 Mar; 39(1):211-233. PubMed ID: 31970590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medulloblastoma: an Old Diagnosis with New Promises.
    Szalontay L; Khakoo Y
    Curr Oncol Rep; 2020 Jul; 22(9):90. PubMed ID: 32643099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Approaches in Targeted Therapy for Medulloblastoma in Children.
    Maier H; Dalianis T; Kostopoulou ON
    Anticancer Res; 2021 Apr; 41(4):1715-1726. PubMed ID: 33813375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matching mice to malignancy: molecular subgroups and models of medulloblastoma.
    Lau J; Schmidt C; Markant SL; Taylor MD; Wechsler-Reya RJ; Weiss WA
    Childs Nerv Syst; 2012 Apr; 28(4):521-32. PubMed ID: 22315164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma.
    McCabe MG; Bäcklund LM; Leong HS; Ichimura K; Collins VP
    Neuro Oncol; 2011 Apr; 13(4):376-83. PubMed ID: 21292688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medulloblastoma epigenetics and the path to clinical innovation.
    Haltom AR; Toll SA; Cheng D; Maegawa S; Gopalakrishnan V; Khatua S
    J Neurooncol; 2020 Oct; 150(1):35-46. PubMed ID: 32816225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Classification Improves Therapeutic Options for Infants and Young Children With Medulloblastoma.
    Bagchi A; Dhanda SK; Dunphy P; Sioson E; Robinson GW
    J Natl Compr Canc Netw; 2023 Aug; 21(10):1097-1105. PubMed ID: 37643637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates on Management of Adult Medulloblastoma.
    Majd N; Penas-Prado M
    Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.